HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Clinical trials for HEMATOLOGIC AND LYMPHOCYTIC DISORDER explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC AND LYMPHOCYTIC DISORDER trials appear
Sign up with your email to follow new studies for HEMATOLOGIC AND LYMPHOCYTIC DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep deadly blood cancer at bay
Disease control OngoingThis study is testing whether a two-drug combination (azacitidine and venetoclax) can help keep acute myeloid leukemia (AML) from returning in patients who have achieved remission. The trial will enroll 50 adults with AML who are in remission but are not immediate candidates for …
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Experimental cell therapy aims to calm transplant rejection
Disease control TerminatedThis early-stage trial is testing a new cell therapy for patients with chronic graft-versus-host disease (cGVHD), a serious complication where donor immune cells attack the patient's body after a bone marrow transplant. Researchers modify a donor's immune cells in the lab to crea…
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug trial aims to stop Body's attack after Life-Saving transplants
Prevention OngoingThis study is testing if adding a new drug called itacitinib to standard treatment can prevent a serious complication called graft-versus-host disease (GVHD) in patients who receive a donor stem cell transplant for blood cancers. GVHD happens when the donor's immune cells attack …
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC
-
New hope to stop dangerous transplant complication
Prevention OngoingThis trial is testing if a drug called ustekinumab can prevent a serious complication called graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. About 116 patients will receive either the drug or a placebo alongside their standard transplant care. The…
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC